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Limitations to the data and subjectivity in the structure-
determination process may cause errors in macromolecular
crystal structures. Appropriate validation techniques may be
used to reveal problems in structures, ideally before they are
analysed, published or deposited. Additionally, such tech-
niques may be used a posteriori to assess the (relative) merits
of a model by potential users. Weak validation methods and
statistics assess how well a model reproduces the information
that was used in its construction (i.e. experimental data and
prior knowledge). Strong methods and statistics, on the other
hand, test how well a model predicts data or information that
were not used in the structure-determination process. These
may be data that were excluded from the process on purpose,
general knowledge about macromolecular structure, informa-
tion about the biological role and biochemical activity of the
molecule under study or its mutants or complexes and pre-
dictions that are based on the model and that can be tested
experimentally.
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1. The ‘why’ of validation
X-ray crystallography is a truly marvellous technique that
enables us to study the structure of organic and inorganic
matter, from simple salts to complex molecular machines.
When the technique is applied to biologically relevant mole-
cules or complexes, the results often provide unique insight
into and understanding of the relationship between structure
and function. For this reason, exciting new crystal structures
regularly adorn the front cover of popular and prestigious
science journals and magazines. Unfortunately, despite all
the progress in instrumentation, methodology, software and
protocols over the past 50 years, crystallographers do make
mistakes. If the resolution of the crystallographic data is high
and the crystallographer is skilled and experienced, there will
probably be no major errors in the ﬁnal model that is depos-
ited and described in a paper. If either the resolution is high
or the crystallographer is skilled, but not both, then it is still
possible that the there will be no major errors. If the resolution
is low and the crystallographer is not very experienced,
however, the probability of serious errors becomes danger-
ously high. In the ‘best-case’ scenario, a ﬂawed structure will
be of limited interest and any serious errors will merely pollute
the structural archive, the Protein Data Bank (PDB; Berman
et al., 2000). In the worst case, serious errors in a high-proﬁle
structure may actually obstruct the progress of science for
years to come, which appears to have happened in the case of
the ﬁve grossly incorrect ABC-transporter structures dis-
cussed elsewhere in this issue (Chang et al., 2006; Miller, 2007;
Korkhov & Tate, 2009; Jeffrey, 2009).It is surprising that the gross errors in the ﬁve ABC-trans-
porter structures were not detected earlier in the laboratory in
which they were solved. However, the fact that other crys-
tallographers did not seriously challenge the structures either
is more easily explained. For the ﬁrst structure only C
 co-
ordinates were deposited and for only one of the ﬁve struc-
tures were the experimental data deposited. The lax attitude
of many journals when it comes to (enforcing) their own
requirements for deposition of not only models but also ex-
perimental data has been criticized for a long time (Jones et al.,
1996; Jones & Kleywegt, 2007; for a discussion of the history of
deposition requirements, see Kleywegt et al., 2004). Fortu-
nately, this is no longer an issue since the worldwide PDB
(wwPDB) has made the deposition of experimental X-ray and
NMR data mandatory as of 1 February 2008. This does not
mean that errors will no longer be made in the future, but
many will hopefully be caught at deposition time and others
may be detected at a later stage as the availability of model
and data allows the calculation of maps [e.g. made available
through the Uppsala Electron-Density Server (EDS); Kley-
wegt et al., 2004] and the re-reﬁnement of models (Joosten et
al., 2009).
There are two aspects to biomacromolecular X-ray crys-
tallography that invite errors to be made: limitations to the
data and subjectivity in the structure-determination process.
Diffraction data collected from biological samples is almost
invariably weak and noisy. The resolution of the data (and
hence its information content) is also usually limited and
sometimes it is not possible to collect complete data sets. The
data that are collected are always averaged in both space
(different molecules inside a crystal, subject to possible static
disorder and twinning phenomena) and time (during data
collection, with possible deleterious effects of radiation
damage, oxidation of the sample or other chemical reactions).
Furthermore, any experimental phases will contain (hopefully
small) errors and calculated phases will be subject to model
bias. Since there is no magical formula to calculate ‘the’ model
from the diffraction data, subjectivity on behalf of the crys-
tallographer also plays an important role (Bra ¨nde ´n & Jones,
1990). Of course, different levels of skill and experience
already come into play in the crystallization, data-collection
and data-processing stages, but mistakes and errors there
usually result in failure to solve the structure rather than in a
publication and a model that later both need to be retracted
(although there are exceptions). Given the same data, no two
crystallographers will ever produce identical ﬁnal models.
Their different biases and skill and experience levels will
manifest themselves especially during manual model building
but also during model reﬁnement (e.g. different ways to
parameterize a model and the use of different reﬁnement
programs and protocols). Even with atomic resolution data,
individual decisions will differ during both model building
(with respect to possible water molecules, alternative confor-
mations, etc.) and reﬁnement [choice of computer program,
atomic displacement parameter (ADP) model, treatment of
noncrystallographic symmetry, target values and weights of
various restraints etc.] (Kleywegt, 2000).
In the ﬁrst 50 years of biomacromolecular crystallography,
there has probably not been a single error-free structure (in
the sense that it cannot be improved upon, now or in the
future). This means ﬁrst of all that crystallographers must do
their utmost to ﬁnd and (if possible) ﬁx the major errors in
their model prior to deposition and publication. However,
since there is no way of keeping even highly suspicious models
out of the public database (or of evicting them), users of
structural information should also ﬁnd out about potentially
problematic aspects of any model they intend to use as a
molecular-replacement probe, to design mutants or ligands, to
produce homology models, to compare with related structures
or to simulate. In other words, validation is crucial for both the
producers and the consumers of biomacromolecular structures
and validation tools should be used both to assess the overall
quality of a model and to assess the reliability of particularly
interesting aspects (active-site residues, interface residues,
ligands, inhibitors, cofactors etc.).
It is important to realise that errors in crystal structures
come in many different shapes and forms. Fortunately, the
most serious ones (e.g. mistracing the fold of an entire protein
domain) are fairly rare because they are normally those that
are most easily detected (provided that the crystallographer
uses appropriate tools and protocols and does not ignore
warning signs). At the other end of the scale are purely clerical
errors that do not change the scattering of the model (e.g.
labelling chemically indistinguishable side-chain atoms in
violation of a convention). Many examples of grossly incorrect
protein crystal structures have been discussed in the past
(Bra ¨nde ´n & Jones, 1990; Kleywegt, 2000; Davis et al., 2008)
and the ABC-transporter ﬁasco shows that this is by no means
a phenomenon that only occurred in the ‘dark ages’ of protein
crystallography. Even when the overall structure of a protein is
essentially correct, models of complexes with small-molecule
ligands can still have a wide variety of problems, as demon-
strated in many papers (Davis et al., 2003, 2008; Kleywegt et
al., 2003; Kleywegt, 2007, and references therein). These
problems include errors in the chemical identity of a ligand,
errors in the stereochemistry or conformation, the modelling
of a phantom ligand or, conversely, misinterpreting ligand
density as a chain of water molecules. Interestingly, crystallo-
graphers are ‘creative’ and manage to produce new types of
errors with regularity. For example, two triclinic structures
published in 2004 had seriously incorrect cell constants owing
to an error in the wavelength. The resulting models had
reasonable geometry (probably thanks to tight restraints) but
the R values for one of them were in excess of 0.3, which
should have raised a few eyebrows given that the resolution
was 1.6 A ˚ . After re-reﬁnement in the correct cell the R values
dropped by 0.1 to a much more acceptable level.
In summary, validation of models is crucial. On one hand, it
helps the crystallographer to pinpoint aspects of the model
that might be in error and need ﬁxing or improving prior to
publication and deposition. Validation thus helps to improve
the quality and integrity of the structural archive. On the other
hand, validation of deposited models informs potential users
about the quality of the model as a whole and of important
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decisions as to the suitability of a model for their speciﬁc
purposes.
2. The ‘what’ of validation
The dictionarydeﬁnition of validation alludes to the processof
establishing, checking or demonstrating the truth, value or
accuracy of, for example, a theory, hypothesis, model or claim.
As such, validation is (or rather ought to be) an integral part
of every scientiﬁc endeavour. It is instructive to consider a
simple model of the way in which hypothesis-driven research
is carried out in the experimental natural sciences (Fig. 1).
Given an interest in a certain area and a certain amount of
prior knowledge, questions can be asked that may be
answered through experimentation (in vivo, in vitro or in
silico). The results of the experiment (possibly after some data
processing) are a set of observations that can be used together
with the prior knowledge to construct a model or hypothesis.
The hypothesis or model will usually be required to have
predictive properties (and thus be falsiﬁable). This model of
doing science is very general: the newly formulated hypothesis
or model may pertain to the mechanism of an enzyme reac-
tion, the evolutionary relatedness of a set of species or pro-
teins, the feeding or breeding habits of zebraﬁsh as a function
of water temperature or, indeed, the three-dimensional
structure of a biological macromolecule. In the latter case, the
model is a set of point scatterers with assigned atom types
(needed to select the appropriate form factors). In most cases,
a mapping of the scatterers to speciﬁc atoms (based on the
chemical diagram of a small molecule or the amino-acid or
nucleotide sequence of a biomacromolecule) will also have
been made. During reﬁnement, the scatterers are usually
considered to be hard spheres connected by springs and a
suitable set of parameters is chosen (Cartesian atomic co-
ordinates or torsion angles, ADPs, occupancies) and reﬁned
subject to a number of restraints and constraints.
In experimental science, errors come in three classes.
Random errors lead to noise and affect the precision of
measurements. Such errors often have a normal distribution
and can be reduced by increasing the number of times a
measurement is repeated. Systematic errors, on the other
hand, affect the accuracy. These errors introduce a bias in the
measurements that arises from, for instance, incomplete
knowledge or inadequate experimental design. In contrast to
random errors, systematic errors are reproducible and
repeating the measurements cannot reduce them. Finally,
gross errors or bloopers may occasionally happen, e.g. owing
to incorrect assumptions, undetected mistakes or instrument
malfunction. In favourable cases, gross errors may be detect-
able as outliers in an experiment. In our simple model of a
research project (Fig. 1), all three kinds of errors can affect the
prior knowledge, the experiment and the resulting observa-
tions. As a consequence, the model or hypothesis may contain
more or less serious errors and these in turn may lead to
incorrect predictions. Without validation, there is no way of
knowing if the model and the predictions can be trusted at all.
Our scheme suggests a few obvious ways to validate the
model (Fig. 2). First, the prior knowledge should always be
examined critically. As Mark Twain once said: ‘The trouble
with most of us is that we know too much that ain’t so’. For
instance, any deposited protein structure that is going to be
used for molecular replacement, mutant or ligand design,
homology modelling or molecular-dynamics simulations ought
to be critically examined prior to use. Secondly, the experi-
mental observations should be assessed in terms of quality and
quantity. In addition, one should always ascertain that the data
have the proper information content to answer the question
one is interested in. For instance, a three-dimensional cryo-
EM map will typically not be suitable to answer questions
about a biological molecule at the level of individual atoms or
even residues and a crystal structure (with its crystal contacts)
will not in general provide an accurate picture of the dynamics
of the molecule in a dilute solution. Thirdly, since the model or
hypothesis is based on a synthesis of the experimental obser-
vations and the prior knowledge, it is important to check that
the model both ﬁts the prior knowledge and explains the
observations. These are necessary conditions, but they are not
sufﬁcient for validation purposes. The fact that both the prior
knowledge and the observations were used directly as input to
the model-synthesis process (e.g. a crystallographic reﬁnement
program) means that such tests only assess whether or not that
process was carried out competently. Validation criteria that
assess the conformance of model and prior knowledge or of
model and experimental data have therefore been termed
‘weak’ (Kleywegt & Jones, 1995b).
To validate a model properly, it is necessary to put its pre-
dictive power to the test. If the model makes or enables pre-
dictions, appropriate experiments can be designed and carried
out. If the results are in agreement with the predictions, then
the conﬁdence in the model is boosted. It may also be the case
that independent observations of the system under study
are available (for instance, reﬂections set aside for cross-
validation purposes or data on the effect of certain point
mutations on the activity or speciﬁcity of an enzyme). If the
model explains such observations, despite the fact that they
were not used in the construction of the model, then this again
research papers
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Figure 1
A simple model ofhypothesis-driven research in the experimental natural
sciences. Prior knowledge leads to a question that can hopefully be
answered by carrying out one or more experiments. The observations and
the prior knowledge are combined to yield a hypothesis or model, which
can be used to make falsiﬁable predictions. In the case of crystallography,
themodel consists of the parameterization and theoptimal values derived
for all parameters.increases the conﬁdence in the model. Finally, there may be
additional prior knowledge that is not speciﬁc to the system
under study and that also has not been used in the construc-
tion of the model (for instance, the core regions of the
Ramachandran plot in which most residues of any newly
determined protein crystal structure are expected to cluster).
If the model is indeed in agreement with such additional prior
knowledge, this can be taken as further evidence that the
model is probably reliable. Validation criteria that assess the
conformance of a model and any data or information that
were not used (directly or indirectly) in the construction of the
model have been termed ‘strong’ (or ‘orthogonal’ to the input
data and prior knowledge; Kleywegt & Jones, 1995b).
3. The ‘how’ of validation
The discussion in the previous section, as well as the validation
scheme shown in Fig. 2, was completely general. An obvious
follow-up question for a crystallographer is: what makes a
crystallographic model a good model? In essence, the answer
to this question is simple: a good model is one that makes
sense in all possible respects that we can think of, now and in
the future (Kleywegt & Jones, 1995b).
The model should ﬁrst of all make sense in terms of
chemistry: bond lengths, bond angles and torsion angles
should have reasonable values, nonstandard compounds (such
as ligands and cofactors) should have correct atom types
assigned, stereo-centres should have the correct handedness,
planar groups should be ﬂat etc. The model should also make
sense in terms of physics: there should be no bad contacts or
atomic overlaps between atoms that are not covalently
bonded (including explicit or implicit H atoms), the core of
proteins should be close-packed, there should be lots of
favourable hydrogen-bonding interactions, charges should
mostly interact with other charges, ADPs should show a
reasonable pattern of variation (e.g. along a side chain or
depending on the degree of solvent exposure) etc. Obviously, a
model should also make sense in terms of crystallography: the
model should explain (and, in the case of unused ‘test-set’
reﬂections, predict) the experimental data without making
unreasonable assumptions and with minimal over-ﬁtting (or
‘under-modelling’), residues should generally ﬁt their own
density well etc. Many of the conditions of chemistry, physics
and crystallography are imposed by the reﬁnement programs,
which makes these checks less useful from a validation
perspective. The model is expected to adhere to these condi-
tions and therefore good overall values for any such statistics
[such as the conventional R value and the root-mean-square
deviation (r.m.s.d.) of bond lengths from ideal values] do not
provide independent proof of the correctness of the model.
Indeed, it has been demonstrated that even an insane model
(intentionally traced backwards through the electron density)
can be reﬁned to yield cosmetically pleasing values of the
conventional R value and statistics such as the r.m.s. bond-
length deviation (Kleywegt & Jones, 1995a). On the other
hand, any outliers of such quality checks should obviously be
examined critically (e.g. unusually long or short covalent
bonds).
For validation purposes, it is more useful to assess the
predictive qualities of a model. In general, three types of data
and information can be used for this (Fig. 2): the ﬁt of the
model to general prior knowledge not used in the construction
of the model, the prediction of any unused observations
speciﬁc to the system under study and predictions of proper-
ties that can be tested experimentally. The use of a ‘test set’ of
reﬂections for cross-validation purposes (Rfree; Kleywegt &
Bru ¨nger, 1996) is an important example of the second cate-
gory. The remainder of these three categories is largely
covered by the requirement that a good model should make
sense in terms of everything we know about macromolecular
structure and in terms of experimental biology and biochem-
istry. In the case of biomacromolecules, underlying physical
and chemical principles manifest themselves in empirically
observed structural regularity. For instance, nonbonded inter-
actions are responsible for the limited set of torsion angles
that are accessible for the main chain of proteins (as mani-
fested in the appearance of the Ramachandran plot) and for
the side chains of amino-acid residues (as manifested in the
abundance of preferred rotamer conformations). Interactions
between atoms that are separated by many bonds but nearby
in space are governed by the same forces, which leads to the
favourable interactions observed in high-resolution well
reﬁned structures (hydrophobic residues pack together,
hydrophilic residues form hydrogen bonds, charged residues
in addition may form salt links). Comparison with the struc-
tures of related molecules (complexes, mutants, orthologues,
paralogues) can also be used for validation purposes: any
unexpected differences should be justiﬁed or at least receive a
plausible explanation. Finally, the whole body of biological
research papers
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Figure 2
Different ways in which a model or hypothesis can be validated. Firstly,
the input to the model itself (prior knowledge and experimental
observations) needs to be validated. Secondly, the model or hypothesis
should ﬁt in with the prior knowledge and explain the experimental
observations (thin arrows). However, the reliability or accuracy of a
model is most convincingly demonstrated by its predictive quality with
respect to data and information that were not used in the construction of
the model (fat arrows). This may entail comparison to new or unused
general prior knowledge, to independent observations pertaining to the
system under study and to the results of experiments that were designed
based on the model.and biochemical data of the molecule(s) under study should
be examined in light of the structure. Ideally, the structure
should explain what is known about the mechanism, substrate
preference, the effects of mutations and inhibitors etc. If such
data are unavailable or deemed unreliable, experiments can
be designed based on the model to assess its predictive value.
Fig. 3 shows some examples of speciﬁc validation criteria
and quality checks that can be carried out on (protein) crystal
structures and how they ﬁt into the general validation scheme
that was discussed in the previous section (and shown in
Fig. 2). An extensive set of such criteria is discussed in Kley-
wegt (2000). Some of the validation and quality statistics will
be calculated by the reﬁnement software, whereas others can
be obtained with programs such as O (Jones et al., 1991),
WHATCHECK (Joosten et al., 2009) or MOLPROBITY
(Davis et al., 2007).
4. Concluding remarks: looking back and looking ahead
In 1990, the subject of the CCP4 Study Weekend was ‘Accu-
racy and Reliability of Macromolecular Crystal Structures’
(Henrick et al., 1990), a topic that overlaps with that of the
2008 meeting.It was inspired by a number of high-proﬁle cases
of serious errors in protein structures (Bra ¨nde ´n & Jones,
1990), including that of the small (S) subunit of tobacco
RuBisCO (Schreuder et al., 1990; Knight et al., 1990). This
structure had essentially been traced backwards through the
density in the Los Angeles model (Schreuder et al., 1990),
whereas it was built correctly in the Uppsala model (Knight et
al., 1990). The analysis of the Uppsala model in the proceed-
ings of the 1990 meeting was (one of) the ﬁrst paper(s) to
mention the word ‘validation’ in the title in relation to a
macromolecular crystal structure (Knight et al., 1990). Inter-
estingly, a number of the arguments that Knight and
coworkers presented to support the correctness of their model
are described as follows:
None of this evidence is dependent on a reﬁned model and
instead makes use of known facts about proteins in general and
the S subunit of RuBisCO in particular
(Knight et al., 1990). These arguments included: (i) the heavy-
atom-binding sites have chemically plausible ligands, (ii) the S
subunit has a well deﬁned hydrophobic core, (ii) conserved
residues are found at the S–L subunit interfaces and (iv) a
deletion in cyanobacterial S subunits occurs within a loop
(Knight et al., 1990). While today most of these aspects can be
investigated on a case-by-case basis using a variety of different
programs, there is clearly scope for the development of
intelligent tools to perform this automatically and in an inte-
grated fashion.
Validation of macromolecular crystal structures ‘at the gate’
(i.e. at the time of deposition at one of the wwPDB nodes) has
historically left something to be desired. In an effort to
improve this situation, the wwPDB consortium has recently
convened a ‘Validation Task Force’ which brings together
many experts in the ﬁeld to advise the wwPDB and also to
contribute computer code and programs (Smith et al., 2009).
One goal of this work is to design a brief validation report with
the most essential reﬁnement and validation statistics that
depositors will receive from the deposition site and that they
can send to the journal to which they submit their manuscript.
This would help editors and referees to judge the quality of
models that have been deposited but are not yet available
from the PDB.
Finally, it should be noted that validation demands that the
model be based on experimental data (for instance, the
Ramachandran plot cannot normally be used to validate
homology models). It is conceivable that models that do not
satisfy this fundamental sine qua non could be (or have been)
deposited and published. While some validation techniques
will no doubt prove useful for detecting such cases, it is likely
that entirely new methods have to be developed to do so
reliably. These methods will probably involve assessment of
the raw or processed experimental data as well as the ﬁt of the
model to the data. Given the gravity of the implications, such
methods should have extremely low false-positive rates.
However, it is important to realise that validation is something
else entirely to fraud detection. Validation can help crystal-
lographers to produce better models (or at least provides a
realistic impression of a model’s strengths and shortcomings)
and users of structural data to pick the model that best suits
their purposes. In short: validation is your friend!
This work was funded by Uppsala University and the
Swedish Research Council (VR). Seventeen years of lively
discussions and a fair number of papers co-authored with
Alwyn Jones have helped to shape the contents of this
contribution.
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